Follow
Ammar Almaaytah
Ammar Almaaytah
Dean and Professor of Pharmaceutical Biotechnology, Jordan University of Science & Technology
Verified email at just.edu.jo
Title
Cited by
Cited by
Year
Scorpion venom peptides with no disulfide bridges: a review
A Almaaytah, Q Albalas
Peptides 51, 35-45, 2014
1952014
Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a …
A Almaaytah, M Zhou, L Wang, T Chen, B Walker, C Shaw
Peptides 35 (2), 291-299, 2012
1082012
Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 Jordanians
TL Mukattash, M Shara, AS Jarab, SI Al-Azzam, A Almaaytah, ...
International Journal of Pharmacy Practice 20 (6), 367-376, 2012
922012
Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria
A Almaaytah, GK Mohammed, A Abualhaijaa, Q Al-Balas
Drug design, development and therapy, 3159-3170, 2017
882017
Dispensing of non-prescribed antibiotics in Jordan
Almaaytah
Patient Preference and Adherence 9, 1389, 2015
852015
Antimicrobial and antibiofilm activity of UP-5, an ultrashort antimicrobial peptide designed using only arginine and biphenylalanine
A Almaaytah, MT Qaoud, G Khalil Mohammed, A Abualhaijaa, D Knappe, ...
Pharmaceuticals 11 (1), 3, 2018
542018
Mauriporin, a Novel Cationic α-Helical Peptide with Selective Cytotoxic Activity Against Prostate Cancer Cell Lines from the Venom of the Scorpion Androctonus mauritanicus
A Almaaytah, S Tarazi, N Mhaidat, Q Al-Balas, T Mukattash
International Journal of Peptide Research and Therapeutics 19 (4), 281-293, 2013
522013
Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1
QAB Ammar Almaaytah, Shadi Tarazi, Ahmad Abu-Alhaijaa
Pharmaceuticals 7 (5), 502-516, 2014
442014
Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides
A Almaaytah
Infection and Drug Resistance 2018 (11), 835—847, 2018
402018
Generation of the first structure-based pharmacophore model containing a selective “zinc binding group” feature to identify potential glyoxalase-1 inhibitors
Q Al-Balas, M Hassan, B Al-Oudat, H Alzoubi, N Mhaidat, A Almaaytah
Molecules 17 (12), 13740-13758, 2012
402012
Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae
S Swedan, Z Shubair, A Almaaytah
Infection and Drug Resistance, 2019-2030, 2019
352019
Antimicrobial and Antibiofilm Activity of Mauriporin, a Multifunctional Scorpion Venom Peptide
A Almaaytah, S Tarazi, F Alsheyab, Q Al-Balas, T Mukattash
International Journal of Peptide Research and Therapeutics, 1-12, 2014
302014
Punicalagin and zinc (II) ions inhibit the activity of SARS-CoV-2 3CL-protease in vitro.
MJ Saadh, AM Almaaytah, M Alaraj, MF Dababneh, I Sa'Adeh, ...
European Review for Medical & Pharmacological Sciences 25 (10), 2021
292021
A3, a scorpion venom derived peptide analogue with potent antimicrobial and potential antibiofilm activity against clinical isolates of multi-drug resistant gram positive bacteria
A Almaaytah, A Farajallah, A Abualhaijaa, Q Al-Balas
Molecules 23 (7), 1603, 2018
292018
Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
IIH Al-Balas QA, Hassan MA, Al-Shar’i NA, Mhaidat NM, Almaaytah AM, Al ...
Drug Design, Development and Therapy 10, 2623—2629, 2016
272016
Prevalence and nature of off-label antibiotic prescribing for children in a tertiary setting: a descriptive study from Jordan
TL Mukattash, WA Hayajneh, SM Ibrahim, A Ayoub, N Ayoub, AS Jarab, ...
Pharmacy Practice (Granada) 14 (3), 0-0, 2016
242016
Virtual lead identification of farnesyltransferase inhibitors based on ligand and structure-based pharmacophore techniques
QA Al-Balas, HA Amawi, MA Hassan, AM Qandil, AM Almaaytah, ...
Pharmaceuticals 6 (6), 700-715, 2013
242013
Combination of pharmacophore modeling and 3D-QSAR analysis of potential glyoxalase-I inhibitors as anticancer agents
MA Al-Sha'er, QA Al-Balas, MA Hassan, GA Al Jabal, AM Almaaytah
Computational Biology and Chemistry 80, 102-110, 2019
232019
Recent advances in glyoxalase-I inhibition
QA Al-Balas, MA Hassan, NA Al-Shar'i, GA Al Jabal, AM Almaaytah
Mini Reviews in Medicinal Chemistry 19 (4), 281-291, 2019
232019
Design and characterization of a new hybrid peptide from LL-37 and BMAP-27
Y Al Tall, A Abualhaijaa, M Alsaggar, A Almaaytah, M Masadeh, ...
Infection and drug resistance, 1035-1045, 2019
212019
The system can't perform the operation now. Try again later.
Articles 1–20